Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Reluctant placebo supplies undermining independent trials
The reluctance of some pharmaceutical companies to supply placebos for independent clinical trials is undermining studies not dictated by commercial objectives, two Danish researchers claim.
“We believe that this could be a major way for the pharmaceutical industry to control scientific information about their drugs,” contend Mikkel Christensen and Filip Knop from the University of Copenhagen in a letter to the 7 January issue of The Lancet.
Christensen and Knop cite an “example known by us” in which an unidentified drug company was approached by researchers for placebo medication, in the form of an injection pen for diabetics, to support an independently financed trial of a marketed product.
The company concerned asked for a full study protocol, which was scrutinised by “an opaque system of evaluation committees”, Christensen and Knop write. After more than six months, they say, the company finally agreed to supply the placebo devices on condition that the protocol was changed in line with its suggestions.
more... ( http://www.pharmatimes.com/Article/12-01-10/Reluctant_placebo_supplies_undermining_independent_trials.aspx )
“We believe that this could be a major way for the pharmaceutical industry to control scientific information about their drugs,” contend Mikkel Christensen and Filip Knop from the University of Copenhagen in a letter to the 7 January issue of The Lancet.
Christensen and Knop cite an “example known by us” in which an unidentified drug company was approached by researchers for placebo medication, in the form of an injection pen for diabetics, to support an independently financed trial of a marketed product.
The company concerned asked for a full study protocol, which was scrutinised by “an opaque system of evaluation committees”, Christensen and Knop write. After more than six months, they say, the company finally agreed to supply the placebo devices on condition that the protocol was changed in line with its suggestions.
more... ( http://www.pharmatimes.com/Article/12-01-10/Reluctant_placebo_supplies_undermining_independent_trials.aspx )
1 replies
= new reply since forum marked as read
= new reply since forum marked as read
